Thieno[3,2-b]pyridine derivatives
AssigneeMitsubishi Kasei Corporation
InventorsAkira Maruyama, Shigeru Ogawa, Satoshi Yamazaki, Akihiro Tobe
Life of this patent
Estimating the term…
Loading patent…
AssigneeMitsubishi Kasei Corporation
InventorsAkira Maruyama, Shigeru Ogawa, Satoshi Yamazaki, Akihiro Tobe
Estimating the term…
The thieno[3.2-b]pyridine derivative of the present invention promote the gastric emptying in male ddy mice and the gastric contraction in dogs sutured with a strain-gauge transducer. It is believed that the derivatives have the action to enhance gastric motor action and gastric emptying. Therefore, the compound of the present invention are effective for the prevention and therapeutical treatment of the symptoms caused by gastric hypanakinesis, such as heartburn, abdominal distension feeling, anorexia, unpleasant feeling on upper abdomen, abdominalgia, nausea, vomiting, etc. caused by the underlying diseases such as acute and chronic gastritis, stomach and duodenum ulcer, gastroneurosis, gastroptosis, etc. The present invention also encompasses a pharmaceutical composition containing as the effective ingredient a compound of the present invention, and a method for producing the same.
A thieno[3,2-b]pyridine derivative represented by formula (I):
A thieno[3,2-b]pyridine derivative represented by formula (Ib'), a pharmaceutically acceptable salt thereof, an N-oxide derivative thereof or a solvate thereof;
A compound according to claim 11, in the form of an optical isomer which has the R-configuration.
R-N-(1-azabicyclo[2.2.2]oct -3-yl)-7-hydroxythieno[3,2-b]pyridine-6-carboxamide hydrochloride.
Dependencies are inferred from the claim text.